During the past decade, Sasebo City General Hospital conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sasebo City General Hospital" #1 sponsor was "Kyowa Kirin Co., Ltd." with 2 trials, followed by "Actelion" with 1 trials sponsored, "Celgene" with 1 trials sponsored, "Coherus Biosciences, Inc." with 1 trials sponsored and "Regeneron Pharmaceuticals" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sasebo City General Hospital" #1 collaborator was "Daiichi Sankyo Co., Ltd." with 1 trials as a collaborator, "EPS Corporation" with 1 trials as a collaborator, "General Laboratory, BML, Inc." with 1 trials as a collaborator, "Imepro Inc." with 1 trials as a collaborator and "Mitsubishi Logistics Corporation" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Sasebo City General Hospital" are "Adult T-Cell Leukemia-Lymphoma" (1 trials), "Adult T-cell Leukemia-Lymphoma" (1 trials), "Advanced Malignancies" (1 trials), "Axial Spondyloarthritis" (1 trials) and "Chronic Thromboembolic Pulmonary Hypertension (CTEPH)" (1 trials). Many other conditions were trialed in "Sasebo City General Hospital" in a lesser frequency.

Most popular intervention types in "Sasebo City General Hospital" are "Drug" (6 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "CHS-0214" (1 trials), "Cemiplimab" (1 trials), "Etanercept" (1 trials), "Gemcitabine" (1 trials) and "Ipilimumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Sasebo City General Hospital" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Sasebo City General Hospital". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Sasebo City General Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Sasebo City General Hospital, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".